| Catalog Number |
07K65-77 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/02/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Event or Problem Description
|
|
The customer observed falsely elevated architect free t4 results for one patient.The initial result was 32.17 pmol/l, recheck result was 17.66 pmol/l (reference range: 9.01-19.05 pmol/l).No impact to patient management was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional patient results added to the ticket on (b)(6) 2024.Initial ft4 test result was 21.11 pmol/l, recheck result was 16.38 pmol/l.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.H3 other text : device evaluation is in progress.
|
| |
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Corrected data found in section d4 catalog # and lot #.
|
| |
|
Additional Manufacturer Narrative
|
|
Data and information provided by the customer were reviewed and support the complaint issue.The ticket search by lot indicates that the reagent lot shows elevated complaint activity, however, in-house performance testing was completed which indicates the product is performing as expected.Device history review did not identify any issues associated with the customer¿s observation.A review of ticket trending did not identify any related trend regarding commonalities for complaint lot number and issue.In-house performance testing was completed which indicates the product is performing as expected.Labeling review concludes that the issue is adequately addressed.Based on the investigation, no systemic issue or deficiency of the architect free t4 assay was identified.
|
| |
|
Search Alerts/Recalls
|